The Genetics of Response to and Side Effects of Lithium Treatment in Bipolar Disorder: Future Research Perspectives

Although the mood stabilizer lithium is a first-line treatment in bipolar disorder, a substantial number of patients do not benefit from it and experience side effects. No clinical tool is available for predicting lithium response or the occurrence of side effects in everyday clinical practice. Mult...

Celý popis

Podrobná bibliografie

Vydáno v:	Frontiers in pharmacology Ročník 12; s. 638882
Hlavní autoři:	Senner, Fanny, Kohshour, Mojtaba Oraki, Abdalla, Safa, Papiol, Sergi, Schulze, Thomas G.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Frontiers Media S.A 25.03.2021
Témata:	bipolar disorder candidate-gene association studies GWAS linkage and segregation studies lithium pharmacogenetics Pharmacology lithium side effect bipolar disorder GWAS treatment response candidate-gene association studies linkage and segregation studies pharmacogenetics
ISSN:	1663-9812, 1663-9812
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!